By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Carl June and Me
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Carl June and Me
Medical Innovations

Carl June and Me

Andrew Schorr
Andrew Schorr
Share
5 Min Read
SHARE

When I was growing up I would read about scientists. I had this image of super smart people in white lab coats being some place far away – untouchable – and hunched behind microscopes. Growing up in the 50’s I thought of Dr. Jonah Salk and what he discovered to wipe out polio. No more pictures of people in iron lungs. Fewer people using crutches or wheelchairs their whole lives. Scientists made it happen.

When I was growing up I would read about scientists. I had this image of super smart people in white lab coats being some place far away – untouchable – and hunched behind microscopes. Growing up in the 50’s I thought of Dr. Jonah Salk and what he discovered to wipe out polio. No more pictures of people in iron lungs. Fewer people using crutches or wheelchairs their whole lives. Scientists made it happen.

But it was a very long time before I actually knew a scientist. After all, I was a journalism major, right? We hung out with the word people and chased the fire trucks and the politicians. Sciences didn’t get the play they deserved.

But as I have devoted myself to medical information and been living with a chronic leukemia, like many other patients where their disease has become chronic rather than terminal, I have paid more and more attention to the leading edge of science, way ahead of what’s being provided at the local clinic, even earlier in the medical research journey than clinic trials in humans. I am now getting excited about what’s happening in the test tube, or on slides under the microscope or in faint hints on the most sophisticated analysis processes.

More Read

biopharmaceuticals
The Price, Cost, and Value of Bio-Pharmaceutical Care
Educating Medical Professionals and Healing with Virtual Reality
Avita Medical’s ReCell Achieves Breakthrough in Leg Ulcer Treatment
Don’t Let Lance Armstrong’s Crash Dampen Your Cancer Hope
Use of Light Technology Avoids Blood Clotting

Dr. Carl June, who directs translational research at the Abramson Cancer Center at the University of Pennsylvania, lives in that world of early research. He is a true scientist. But because he works in translational research he tries to move science into the clinic as soon as is wise. This is the stuff early, phase I, clinical trials are made of.

I have met Carl several times. The first was about three years ago when he spoke about his research in blood cancers while we toured his new center. He was trying to rev up a cancer patient’s immune system to kill the cancer cells it missed when the cancer developed the first time around, and to then have the immune system provide active surveillance so cancer cells could not grow again. Scientists around the world have been trying to do this for years.

But guess what? Carl June and his collaborators may have made real progress in making it happen. A couple of weeks ago a prestigious  journal reported that this team has treated three patients with advanced chronic lymphocytic leukemia (CLL), the same disease I have, with a genetically altered HIV virus. The virus targeted the B-cells of the patients, healthy ones and the millions of cancerous ones. And in two of the patients gave them a new lease on life, a complete remission. The third received a partial remission. They are trying to figure out why the difference.

This is not necessarily “kindler, gentler” cancer therapy. But it may well be lifesaving and have tremendous lessons in the fight against many other cancers. Now Carl and others on the team like Dr. David Porter are on the interview circuit. They are in the NY Times today. Everyone wants to talk to them and Penn reports 5,000 patients with a wide range of cancers have written Carl to see if the experimental medicine can help them. He needs patients for expanded research and he should have no problem as people line up.

I have interviewed Carl a few times. He  seems to be an unassuming man. Not at all a showman. Not at all slick. Just dedicated to science. We hope to interview him again in a week or so, specifically for CLL and lymphoma patients who rely on us.

In the meantime, I guess I know a real scientist now and the significance of what discoveries they make has become much more personal. What Carl has done could one day save my life.

Wishing you and your family the best of health!

Andrew

TAGGED:cancerimmunotherapy
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

In-Home Care Goes High Tech

June 23, 2011
telemedicine
DiagnosticseHealthMedical DevicesMedical InnovationsMobile HealthRemote DiagnosticsTechnology

Telemedicine Robots Let Doctors “Beam” into Hospitals

March 27, 2014
Image
Medical DevicesMedical InnovationsTechnology

Product Differentiation in the Medical Space

May 13, 2016
Jain and Merck
DiagnosticsHealth ReformHospital AdministrationMedical InnovationsMedical RecordsTechnology

How Merck’s Jain is Helping Pharma Catch up to the Digital Health Movement

September 18, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?